<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36125898</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2379-3708</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>21</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>08</Day></PubDate></JournalIssue><Title>JCI insight</Title><ISOAbbreviation>JCI Insight</ISOAbbreviation></Journal><ArticleTitle>Hyperglycemia exacerbates dengue virus infection by facilitating poly(A)-binding protein-mediated viral translation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e142805</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1172/jci.insight.142805</ELocationID><Abstract><AbstractText>Diabetes mellitus (DM) is highly comorbid with severe dengue diseases; however, the underlying mechanisms are unclear. Patients with DM have a 1.61-fold increased risk of developing dengue hemorrhagic fever. In search of host factors involved in dengue virus (DENV) infection, we used high-glucose (HG) treatment and showed that HG increased viral protein expression and virion release but had no effects on the early stages of viral infection. After HG stimulation, DENV-firefly luciferase-transfected assay and cellular replicon-based assay indicated increased viral translation, whereas using the glucose uptake inhibitor phloretin blocked this effect. HG treatment increased the translational factor poly(A)-binding protein (PABP) in a glucose transporter-associated, PI3K/AKT-regulated manner. Silencing PABP significantly decreased HG-prompted virion production. HG enhanced the formation of the PABP-eukaryotic translation initiation factor 4G complex, which is regulated by protein-disulfide isomerase. Hyperglycemia increased PABP expression, mortality rate, viral protein expression, and viral loads in streptozotocin-induced DM mice. Overall, hyperglycemic stress facilitates DENV infection by strengthening PABP-mediated viral translation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Ting-Jing</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chia-Ling</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Tsung-Ting</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jhan</LastName><ForeName>Ming-Kai</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Chyi-Huey</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Research Center of Biostatistics, College of Management, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yen</LastName><ForeName>Yu-Chun</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Research Center of Biostatistics, College of Management, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Ching-Wen</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Research Center of Biostatistics, College of Management, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Cheng-Yi</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Epidemic Intelligence Center, Taiwan Centers for Disease Control, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ministry of Health and Welfare, Institute of Health Policy and Management, College of Public Health, National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Po-Chun</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Chia-Yi</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chiou-Feng</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Diseases and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JCI Insight</MedlineTA><NlmUniqueID>101676073</NlmUniqueID><ISSNLinking>2379-3708</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.1.-</RegistryNumber><NameOfSubstance UI="D019869">Phosphatidylinositol 3-Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D039102">Poly(A)-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014176" MajorTopicYN="N">Protein Biosynthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039102" MajorTopicYN="N">Poly(A)-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="Y">Dengue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006943" MajorTopicYN="Y">Hyperglycemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diabetes</Keyword><Keyword MajorTopicYN="N">Infectious disease</Keyword><Keyword MajorTopicYN="N">Mouse models</Keyword><Keyword MajorTopicYN="N">Translation</Keyword><Keyword MajorTopicYN="N">Virology</Keyword></KeywordList><CoiStatement><b>Conflict of interest:</b> The authors have declared that no conflict of interest exists.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>20</Day><Hour>12</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36125898</ArticleId><ArticleId IdType="pmc">PMC9675471</ArticleId><ArticleId IdType="doi">10.1172/jci.insight.142805</ArticleId><ArticleId IdType="pii">142805</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bhatt S, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504&#x2013;507. doi: 10.1038/nature12060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12060</ArticleId><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam R, et al. Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past. Virol Sin. 2015;30(5):326&#x2013;343. doi: 10.1007/s12250-015-3624-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-015-3624-1</ArticleId><ArticleId IdType="pmc">PMC8200867</ArticleId><ArticleId IdType="pubmed">26494479</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, Cohen SN. Dengue hemorrhagic fever at 60 years: early evolution of concepts of causation and treatment. Microbiol Mol Biol Rev. 2015;79(3):281&#x2013;291. doi: 10.1128/MMBR.00009-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00009-15</ArticleId><ArticleId IdType="pmc">PMC4488372</ArticleId><ArticleId IdType="pubmed">26085471</ArticleId></ArticleIdList></Reference><Reference><Citation>Screaton G, et al. New insights into the immunopathology and control of dengue virus infection. Nat Rev Immunol. 2015;15(12):745&#x2013;759. doi: 10.1038/nri3916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3916</ArticleId><ArticleId IdType="pubmed">26603900</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. Dengue antibody-dependent enhancement: knowns and unknowns. Microbiol Spectr. 2014;2(6) doi: 10.1128/microbiolspec.AID-0022-2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/microbiolspec.AID-0022-2014</ArticleId><ArticleId IdType="pubmed">26104444</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim SP, et al. Ten years of dengue drug discovery: progress and prospects. Antiviral Res. 2013;100(2):500&#x2013;519. doi: 10.1016/j.antiviral.2013.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2013.09.013</ArticleId><ArticleId IdType="pubmed">24076358</ArticleId></ArticleIdList></Reference><Reference><Citation>Htun NS, et al. Is diabetes a risk factor for a severe clinical presentation of dengue?--review and meta-analysis. PLoS Negl Trop Dis. 2015;9(4):e0003741. doi: 10.1371/journal.pntd.0003741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003741</ArticleId><ArticleId IdType="pmc">PMC4409149</ArticleId><ArticleId IdType="pubmed">25909658</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang J, et al. Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study. PLoS Negl Trop Dis. 2012;6(5):e1641. doi: 10.1371/journal.pntd.0001641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001641</ArticleId><ArticleId IdType="pmc">PMC3341340</ArticleId><ArticleId IdType="pubmed">22563519</ArticleId></ArticleIdList></Reference><Reference><Citation>Loghmani E. Diabetes mellitis: type 1 and type 2. Diabetelogia. 2005;27:998&#x2013;1010.</Citation></Reference><Reference><Citation>Jusuf H, et al. DHF with complication of acute pancreatitis related hyperglycemia: a case report. Southeast Asian J Trop Med Public Health. 1998;29(2):367&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">9886129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijekoon CN, Wijekoon PW. Dengue hemorrhagic fever presenting with acute pancreatitis. Southeast Asian J Trop Med Public Health. 2010;41(4):864&#x2013;866.</Citation><ArticleIdList><ArticleId IdType="pubmed">21073060</ArticleId></ArticleIdList></Reference><Reference><Citation>Supradish PO, et al. Dengue hemorrhagic fever grade III with diabetic ketoacidosis: a case report. J Med Assoc Thai. 2011;94(suppl 3):S233&#x2013;S240.</Citation><ArticleIdList><ArticleId IdType="pubmed">22043783</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CY, et al. Diabetes mellitus increases severity of thrombocytopenia in dengue-infected patients. Int J Mol Sci. 2015;16(2):3820&#x2013;3830. doi: 10.3390/ijms16023820.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms16023820</ArticleId><ArticleId IdType="pmc">PMC4346928</ArticleId><ArticleId IdType="pubmed">25674854</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan X, et al. High glucose enhances HIV entry into T cells through upregulation of CXCR4. J Leukoc Biol. 2013;94(4):769&#x2013;777. doi: 10.1189/jlb.0313142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0313142</ArticleId><ArticleId IdType="pmc">PMC3774843</ArticleId><ArticleId IdType="pubmed">23911867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar M, et al. Impaired virus clearance, compromised immune response and increased mortality in type 2 diabetic mice infected with West Nile virus. PLoS One. 2012;7(8):e44682. doi: 10.1371/journal.pone.0044682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0044682</ArticleId><ArticleId IdType="pmc">PMC3432127</ArticleId><ArticleId IdType="pubmed">22953001</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Brufsky A. Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic. J Med Virol. 2020;92(7):770&#x2013;775. doi: 10.1002/jmv.25887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25887</ArticleId><ArticleId IdType="pmc">PMC7262330</ArticleId><ArticleId IdType="pubmed">32293710</ArticleId></ArticleIdList></Reference><Reference><Citation>Flipse J, et al. Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans. Traffic. 2013;14(1):25&#x2013;35. doi: 10.1111/tra.12012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12012</ArticleId><ArticleId IdType="pubmed">22998156</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomila RC, et al. NF90 binds the dengue virus RNA 3&#x2019; terminus and is a positive regulator of dengue virus replication. PLoS One. 2011;6(2):e16687. doi: 10.1371/journal.pone.0016687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0016687</ArticleId><ArticleId IdType="pmc">PMC3046124</ArticleId><ArticleId IdType="pubmed">21386893</ArticleId></ArticleIdList></Reference><Reference><Citation>Dechtawewat T, et al. Role of human heterogeneous nuclear ribonucleoprotein C1/C2 in dengue virus replication. Virol J. 2015;12:14. doi: 10.1186/s12985-014-0219-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-014-0219-7</ArticleId><ArticleId IdType="pmc">PMC4351676</ArticleId><ArticleId IdType="pubmed">25890165</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunetti JE, et al. The heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a host factor required for dengue virus and Jun&#xed;n virus multiplication. Virus Res. 2015;203:84&#x2013;91. doi: 10.1016/j.virusres.2015.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2015.04.001</ArticleId><ArticleId IdType="pubmed">25865411</ArticleId></ArticleIdList></Reference><Reference><Citation>De Nova-Ocampo M, et al. Translation elongation factor-1alpha, La, and PTB interact with the 3&#x2019; untranslated region of dengue 4 virus RNA. Virology. 2002;295(2):337&#x2013;347. doi: 10.1006/viro.2002.1407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2002.1407</ArticleId><ArticleId IdType="pubmed">12033793</ArticleId></ArticleIdList></Reference><Reference><Citation>Paranjape SM, Harris E. Y box-binding protein-1 binds to the dengue virus 3&#x2019;-untranslated region and mediates antiviral effects. J Biol Chem. 2007;282(42):30497&#x2013;30508. doi: 10.1074/jbc.M705755200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M705755200</ArticleId><ArticleId IdType="pubmed">17726010</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y, et al. Functional interaction between cellular p100 and the dengue virus 3&#x2019; UTR. J Gen Virol. 2011;92(pt 4):796&#x2013;806. doi: 10.1099/vir.0.028597-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.028597-0</ArticleId><ArticleId IdType="pubmed">21148275</ArticleId></ArticleIdList></Reference><Reference><Citation>Polacek C, et al. Poly(A)-binding protein binds to the non-polyadenylated 3&#x2019; untranslated region of dengue virus and modulates translation efficiency. J Gen Virol. 2009;90(pt 3):687&#x2013;692. doi: 10.1099/vir.0.007021-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.007021-0</ArticleId><ArticleId IdType="pubmed">19218215</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith RW, et al. Poly(A)-binding proteins are required for diverse biological processes in metazoans. Biochem Soc Trans. 2014;42(4):1229&#x2013;1237. doi: 10.1042/BST20140111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20140111</ArticleId><ArticleId IdType="pmc">PMC4128646</ArticleId><ArticleId IdType="pubmed">25110030</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgui I, et al. PABP1 and eIF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes. J Gen Virol. 2003;84(pt 12):3263&#x2013;3274. doi: 10.1099/vir.0.19487-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.19487-0</ArticleId><ArticleId IdType="pubmed">14645908</ArticleId></ArticleIdList></Reference><Reference><Citation>Svitkin YV, et al. Poly(A)-binding protein interaction with elF4G stimulates picornavirus IRES-dependent translation. RNA. 2001;7(12):1743&#x2013;1752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1370214</ArticleId><ArticleId IdType="pubmed">11780631</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni SD, et al. Glucose-stimulated translation regulation of insulin by the 5&#x2019; UTR-binding proteins. J Biol Chem. 2011;286(16):14146&#x2013;14156. doi: 10.1074/jbc.M110.190553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.190553</ArticleId><ArticleId IdType="pmc">PMC3077616</ArticleId><ArticleId IdType="pubmed">21357685</ArticleId></ArticleIdList></Reference><Reference><Citation>Murira A, Lamarre A. Type-I interferon responses: from friend to foe in the battle against chronic viral infection. Front Immunol. 2016;7:609. doi: 10.3389/fimmu.2016.00609.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00609</ArticleId><ArticleId IdType="pmc">PMC5165262</ArticleId><ArticleId IdType="pubmed">28066419</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond MS. Mechanisms of evasion of the type I interferon antiviral response by flaviviruses. J Interferon Cytokine Res. 2009;29(9):521&#x2013;530. doi: 10.1089/jir.2009.0069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2009.0069</ArticleId><ArticleId IdType="pubmed">19694536</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohio HP, Adamson AL. Glycolytic control of vacuolar-type ATPase activity: a mechanism to regulate influenza viral infection. Virology. 2013;444(1&#x2013;2):301&#x2013;309. doi: 10.1016/j.virol.2013.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2013.06.026</ArticleId><ArticleId IdType="pubmed">23876457</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao JC, et al. The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR. PLoS Negl Trop Dis. 2018;12(8):e0006715. doi: 10.1371/journal.pntd.0006715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0006715</ArticleId><ArticleId IdType="pmc">PMC6117097</ArticleId><ArticleId IdType="pubmed">30125275</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu YC, et al. Identification of a small-molecule inhibitor of dengue virus using a replicon system. Arch Virol. 2012;157(4):681&#x2013;688. doi: 10.1007/s00705-012-1224-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-012-1224-z</ArticleId><ArticleId IdType="pubmed">22249364</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen X, et al. Phloretin exerts hypoglycemic effect in streptozotocin-induced diabetic rats and improves insulin resistance in vitro. Drug Des Devel Ther. 2017;11:313&#x2013;324. doi: 10.2147/DDDT.S127010.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S127010</ArticleId><ArticleId IdType="pmc">PMC5304989</ArticleId><ArticleId IdType="pubmed">28223777</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidet K, Garcia-Blanco MA. Flaviviral RNAs: weapons and targets in the war between virus and host. Biochem J. 2014;462(2):215&#x2013;230. doi: 10.1042/BJ20140456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20140456</ArticleId><ArticleId IdType="pubmed">25102029</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvera D, et al. Translational control in cancer. Nat Rev Cancer. 2010;10(4):254&#x2013;266. doi: 10.1038/nrc2824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc2824</ArticleId><ArticleId IdType="pubmed">20332778</ArticleId></ArticleIdList></Reference><Reference><Citation>Takei N, Nawa H. mTOR signaling and its roles in normal and abnormal brain development. Front Mol Neurosci. 2014;7:28. doi: 10.3389/fnmol.2014.00028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2014.00028</ArticleId><ArticleId IdType="pmc">PMC4005960</ArticleId><ArticleId IdType="pubmed">24795562</ArticleId></ArticleIdList></Reference><Reference><Citation>Diwaker D, et al. Protein disulfide isomerase mediates dengue virus entry in association with lipid rafts. Viral Immunol. 2015;28(3):153&#x2013;160. doi: 10.1089/vim.2014.0095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2014.0095</ArticleId><ArticleId IdType="pubmed">25664880</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan SW, et al. Endothelial cell surface expression of protein disulfide isomerase activates &#x3b2;1 and &#x3b2;3 integrins and facilitates dengue virus infection. J Cell Biochem. 2012;113(5):1681&#x2013;1691. doi: 10.1002/jcb.24037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.24037</ArticleId><ArticleId IdType="pubmed">22422622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge J, et al. Small molecule probe suitable for in situ profiling and inhibition of protein disulfide isomerase. ACS Chem Biol. 2013;8(11):2577&#x2013;2585. doi: 10.1021/cb4002602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cb4002602</ArticleId><ArticleId IdType="pubmed">24070012</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho MR, et al. Blockade of dengue virus infection and viral cytotoxicity in neuronal cells in vitro and in vivo by targeting endocytic pathways. Sci Rep. 2017;7(1):6910. doi: 10.1038/s41598-017-07023-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-07023-z</ArticleId><ArticleId IdType="pmc">PMC5537343</ArticleId><ArticleId IdType="pubmed">28761128</ArticleId></ArticleIdList></Reference><Reference><Citation>Jhan MK, et al. Anti-TNF-&#x3b1; restricts dengue virus-induced neuropathy. J Leukoc Biol. 2018;104(5):961&#x2013;968. doi: 10.1002/JLB.MA1217-484R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.MA1217-484R</ArticleId><ArticleId IdType="pubmed">30044892</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai TT, et al. Microglia retard dengue virus-induced acute viral encephalitis. Sci Rep. 2016;6:27670. doi: 10.1038/srep27670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep27670</ArticleId><ArticleId IdType="pmc">PMC4899773</ArticleId><ArticleId IdType="pubmed">27279150</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen TJ, et al. A murine model of dengue virus-induced acute viral encephalitis-like disease. J Vis Exp. 2019;(146) doi: 10.3791/59132.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/59132</ArticleId><ArticleId IdType="pubmed">31081826</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai TT, et al. Targeting heat shock factor 1 as an antiviral strategy against dengue virus replication in vitro and in vivo. Antiviral Res. 2017;145:44&#x2013;53. doi: 10.1016/j.antiviral.2017.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.07.008</ArticleId><ArticleId IdType="pubmed">28733114</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Bag J. Negative control of the poly(A)-binding protein mRNA translation is mediated by the adenine-rich region of its 5&#x2019;-untranslated region. J Biol Chem. 1998;273(51):34535&#x2013;34542. doi: 10.1074/jbc.273.51.34535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.51.34535</ArticleId><ArticleId IdType="pubmed">9852123</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornstein E, et al. The expression of poly(A)-binding protein gene is translationally regulated in a growth-dependent fashion through a 5&#x2019;-terminal oligopyrimidine tract motif. J Biol Chem. 1999;274(3):1708&#x2013;1714. doi: 10.1074/jbc.274.3.1708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.3.1708</ArticleId><ArticleId IdType="pubmed">9880551</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorgoni B, Gray NK. The roles of cytoplasmic poly(A)-binding proteins in regulating gene expression: a developmental perspective. Brief Funct Genomic Proteomic. 2004;3(2):125&#x2013;141. doi: 10.1093/bfgp/3.2.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bfgp/3.2.125</ArticleId><ArticleId IdType="pubmed">15355595</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HH, et al. AR-12 suppresses dengue virus replication by down-regulation of PI3K/AKT and GRP78. Antiviral Res. 2017;142:158&#x2013;168. doi: 10.1016/j.antiviral.2017.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.02.015</ArticleId><ArticleId IdType="pubmed">28238876</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CJ, et al. Flavivirus activates phosphatidylinositol 3-kinase signaling to block caspase-dependent apoptotic cell death at the early stage of virus infection. J Virol. 2005;79(13):8388&#x2013;8399. doi: 10.1128/JVI.79.13.8388-8399.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.13.8388-8399.2005</ArticleId><ArticleId IdType="pmc">PMC1143730</ArticleId><ArticleId IdType="pubmed">15956583</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprokholt JK, et al. RIG-I-like receptor triggering by dengue virus drives dendritic cell immune activation and TH1 differentiation. J Immunol. 2017;198(12):4764&#x2013;4771. doi: 10.4049/jimmunol.1602121.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1602121</ArticleId><ArticleId IdType="pubmed">28507028</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z, et al. Activation of Toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-&#x3b2; in cultured hepatoma cells. PLoS One. 2011;6(8):e23346. doi: 10.1371/journal.pone.0023346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023346</ArticleId><ArticleId IdType="pmc">PMC3150425</ArticleId><ArticleId IdType="pubmed">21829730</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond MS, Harris E. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Virology. 2001;289(2):297&#x2013;311. doi: 10.1006/viro.2001.1114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1114</ArticleId><ArticleId IdType="pubmed">11689052</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki Y, et al. Characterization of RyDEN (C19orf66) as an interferon-stimulated cellular inhibitor against dengue virus replication. PLoS Pathog. 2016;12(1):e1005357. doi: 10.1371/journal.ppat.1005357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005357</ArticleId><ArticleId IdType="pmc">PMC4703206</ArticleId><ArticleId IdType="pubmed">26735137</ArticleId></ArticleIdList></Reference><Reference><Citation>Balinsky CA, et al. IRAV (FLJ11286), an interferon-stimulated gene with antiviral activity against dengue virus, interacts with MOV10. J Virol. 2017;91(5):e01606-16. doi: 10.1128/JVI.01606-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01606-16</ArticleId><ArticleId IdType="pmc">PMC5309953</ArticleId><ArticleId IdType="pubmed">27974568</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu KH, et al. The apple polyphenol phloretin inhibits breast cancer cell migration and proliferation via inhibition of signals by type 2 glucose transporter. J Food Drug Anal. 2018;26(1):221&#x2013;231. doi: 10.1016/j.jfda.2017.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfda.2017.03.009</ArticleId><ArticleId IdType="pmc">PMC9332637</ArticleId><ArticleId IdType="pubmed">29389559</ArticleId></ArticleIdList></Reference><Reference><Citation>Xintaropoulou C, et al. A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models. Oncotarget. 2015;6(28):25677&#x2013;25695. doi: 10.18632/oncotarget.4499.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.4499</ArticleId><ArticleId IdType="pmc">PMC4694858</ArticleId><ArticleId IdType="pubmed">26259240</ArticleId></ArticleIdList></Reference><Reference><Citation>Hundal RS, et al. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes. 2000;49(12):2063&#x2013;2069. doi: 10.2337/diabetes.49.12.2063.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.49.12.2063</ArticleId><ArticleId IdType="pmc">PMC2995498</ArticleId><ArticleId IdType="pubmed">11118008</ArticleId></ArticleIdList></Reference><Reference><Citation>Htun HL, et al. Metformin use and severe dengue in diabetic adults. Sci Rep. 2018;8(1):3344. doi: 10.1038/s41598-018-21612-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-21612-6</ArticleId><ArticleId IdType="pmc">PMC5820327</ArticleId><ArticleId IdType="pubmed">29463812</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith RW, Gray NK. Poly(A)-binding protein (PABP): a common viral target. Biochem J. 2010;426(1):1&#x2013;12. doi: 10.1042/BJ20091571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20091571</ArticleId><ArticleId IdType="pubmed">20102337</ArticleId></ArticleIdList></Reference><Reference><Citation> World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd edition.  https://apps.who.int/iris/bitstream/handle/10665/41988/9241545003_eng.pdf?sequence=1&amp;isAllowed=y 1997. Accessed September 19, 2022.</Citation></Reference><Reference><Citation>Zhang SL, et al. A simple method for Alexa Fluor dye labelling of dengue virus. J Virol Methods. 2010;167(2):172&#x2013;177. doi: 10.1016/j.jviromet.2010.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2010.04.001</ArticleId><ArticleId IdType="pubmed">20399231</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekel Y, et al. Insights into modeling streptozotocin-induced diabetes in ICR mice. Lab Anim (NY) 2009;38(2):55&#x2013;60. doi: 10.1038/laban0209-55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/laban0209-55</ArticleId><ArticleId IdType="pubmed">19165193</ArticleId></ArticleIdList></Reference><Reference><Citation>Furman BL. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol. 2015;70:5.47.1&#x2013;5.47.20. doi: 10.1002/0471141755.ph0547s70.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471141755.ph0547s70</ArticleId><ArticleId IdType="pubmed">26331889</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>